Product
BAFFR-CAR T cells
2 clinical trials
2 indications
Indication
B-cell Acute Lymphoblastic LeukemiaIndication
B-cell Non-Hodgkin's LymphomaClinical trial
A Phase 1 Study Evaluating BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-cell Acute Lymphoblastic LeukemiaStatus: Recruiting, Estimated PCD: 2026-11-18
Clinical trial
A Phase 1 Study Evaluating BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL)Status: Recruiting, Estimated PCD: 2027-07-13